Trial watch: peptide-based vaccines in anticancer therapy

L Bezu, O Kepp, G Cerrato, J Pol, J Fucikova… - …, 2018 - Taylor & Francis
Peptide-based anticancer vaccination aims at stimulating an immune response against one
or multiple tumor-associated antigens (TAAs) following immunization with purified …

[HTML][HTML] CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials

Z Zhang, JCT Kuo, S Yao, C Zhang, H Khan, RJ Lee - Pharmaceutics, 2021 - mdpi.com
CpG oligodeoxynucleotides (CpG ODNs), the artificial versions of unmethylated CpG motifs
that were originally discovered in bacterial DNA, are demonstrated not only as potent …

Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG

Y Gu, Y Liu, L Fu, L Zhai, J Zhu, Y Han, Y Jiang… - Nature medicine, 2019 - nature.com
Primary tumors may create the premetastatic niche in secondary organs for subsequent
metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles …

[HTML][HTML] Anti-cancer auto-antibodies: Roles, applications and open issues

H de Jonge, L Iamele, M Maggi, G Pessino, C Scotti - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the main causes of death worldwide and early detection
is crucial for effective treatment. Scientists have therefore focused on the identification of …

Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma

W Peng, LJ Williams, C Xu, B Melendez… - Clinical Cancer …, 2019 - AACR
Purpose: OX40 agonist–based combinations are emerging as a novel avenue to improve
the effectiveness of cancer immunotherapy. To better guide its clinical development, we …

[HTML][HTML] Pharmacological activation of cGAS for cancer immunotherapy

KM Garland, JC Rosch, CS Carson… - Frontiers in …, 2021 - frontiersin.org
When compartmentally mislocalized within cells, nucleic acids can be exceptionally
immunostimulatory and can even trigger the immune-mediated elimination of cancer …

Y-shaped oligonucleotides: a promising platform for enhanced therapy with siRNA and CpG Oligodeoxyribonucleotides

IS Yoon, HJ Nam, CA Hong - Biotechnology and Bioprocess Engineering, 2024 - Springer
Nucleic acids (DNA and RNA) have been recognized as promising building blocks to
fabricate a variety of well-defined two-and three-dimensional architectures through the …

Cytosine-phosphate-guanine oligodeoxynucleotides regulate the cell cycle, apoptosis, and steroidogenesis of mouse ovarian granulosa cells by targeting inhibin …

M Yang, J Feng, X Lan, Y Tang, Y Zhang… - In Vitro Cellular & …, 2022 - Springer
Cytosine-phosphate-guanine oligodeoxynucleotides (CpG-ODNs), which exist in vertebrate,
bacterial, and viral genomes, are regarded as strong immune adjuvants. To date, the …

Engineering Innate Immune Activators for Intratumoral Immunotherapy

KM Garland - 2021 - ir.vanderbilt.edu
The development of cancer occurs when immunosuppression inhibits the naturally occurring
process through which the immune system recognizes and eliminates cancer cells (ie the …

[PDF][PDF] Anti-cancer auto-antibodies: roles, applications and open issues. Cancers 2021, 13, 813

H De Jonge, L Iamele, M Maggi, G Pessino, C Scotti - 2021 - academia.edu
Auto-antibodies are classically associated with autoimmune diseases, where they are an
integral part of diagnostic panels. However, recent evidence is accumulating on the …